Suchergebnisse - "Taylor, Graham S."

PubPharm (5)

1

Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma

enthalten in: The Journal of pathology | 2015

von Yap, L. | Velapasamy, S. | Lee, H. | +11

2

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

enthalten in: Blood | 2010

von Fox, C. | Haigh, T. | Taylor, G. | +10

CommentIn: Blood. 2010 Nov 11;116(19):3691-2. - PMID 21071613

3

CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients

enthalten in: Cancer immunology, immunotherapy : CII | 2008

von Lin, X. | Gudgeon, N. | Hui, E. | +7

4

EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets : LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2008

von Haigh, T. | Lin, X. | Jia, H. | +4

5

Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes

enthalten in: Journal of virology | 2005

von Khan, N. | Bruton, R. | Taylor, G. | +4

1
[1]